Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonists of IL17C for the treatment of inflammatory disorders

Antagonists of IL17C for the treatment of inflammatory disorders

US Patent 10815297 · Granted Oct 27, 2020

Estimated economic value: $1,943,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and pharmaceutical compositions thereof for the treatment of inflammat2025
Methods for the treatment of polycystic kidney disease2025
Methods for the treatment of polycystic kidney disease2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases2025
Compounds and pharmaceutical compositions thereof for the treatment of inflammat2023
Humanized antibodies for CD32022
Polypeptide library2021
Compounds and pharmaceutical compositions thereof for the treatment of inflammat2021
Polypeptide library2020
Antagonists of IL-17C for the treatment and/or prevention of atopic dermatitis2020
Compounds and pharmaceutical compositions thereof for the treatment of inflammat2020
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile deriva2019